| Literature DB >> 16242018 |
T Solakivi1, O Jaakkola, A Salomäki, N Peltonen, S Metso, T Lehtimäki, H Jokela, S T Nikkari.
Abstract
BACKGROUND: Oxidative modification of low-density lipoprotein (LDL) is a key event in the oxidation hypothesis of atherogenesis. Some in vitro experiments have previously suggested that high-density lipoprotein (HDL) co-incubated with LDL prevents Cu2+-induced oxidation of LDL, while some other studies have observed an opposite effect. To comprehensively clarify the role of HDL in this context, we isolated LDL, HDL2 and HDL3 from sera of 61 free-living individuals (33 women and 28 men).Entities:
Mesh:
Substances:
Year: 2005 PMID: 16242018 PMCID: PMC1285367 DOI: 10.1186/1476-511X-4-25
Source DB: PubMed Journal: Lipids Health Dis ISSN: 1476-511X Impact factor: 3.876
Characteristics of the study subjects.
| Women | Men | All | |
| N | 32 | 27 | 59 |
| Age (years) | 39.3 ± 10.5 | 39.3 ± 11.0 | 39.3 ± 10.6 |
| Body mass index (kg/m2) | 23.2 ± 3.1 | 25.8 ± 3.6** | 24.4 ± 3.6 |
| Total cholesterol (mmol/l) | 5.23 ± 0.87 | 5.76 ± 1.02* | 5.47 ± 0.97 |
| Triacylglycerol (mmol/l) | 0.96 ± 0.41 | 1.81 ± 1.27*** | 1.35 ± 0.71 |
| HDL cholesterol (mmol/l) | 1.88 ± 0.32 | 1.38 ± 0.23*** | 1.65 ± 0.38 |
| LDL cholesterol (mmol/l) | 2.91 ± 0.84 | 3.63 ± 0.92** | 3.21 ± 0.96 |
| ApoA-I (g/l) | 1.70 ± 0.20 | 1.46 ± 0.13*** | 1.59 ± 0.21 |
| ApoB (g/l) | 0.81 ± 0.20 | 1.00 ± 0.22** | 0.90 ± 0.23 |
| Lp(a) (U/l) | 266 ± 226 | 165 ± 201 | 220 ± 219 |
| fB-Glucose (mmol/l)a | 4.4 ± 0.4 | 4.6 ± 0.6 | 4.5 ± 0.5 |
| LDL diameter (nm) | 26.94 ± 0.45 | 26.40 ± 0.55*** | 26.70 ± 0.51 |
Values are mean ± SD. a fB, fasting blood, * p < 0.05, ** p < 0.01, *** p < 0.001 compared to women by Mann-Whitney U-test.
Percentage composition of fatty acids of LDL, HDL2 and HDL3 in 59 healthy subjects.
| Women | Men | |||||
| Fatty acid | LDL | HDL2 | HDL3 | LDL | HDL2 | HDL3 |
| 14:0 | 0.80 ± 0.22 | 0.67 ± 0.19 | 0.61 ± 0.17 | 0.97 ± 0.29* | 0.94 ± 1.41*** | 0.76 ± 0.26* |
| 16:0 | 19.50 ± 1.27 | 22.68 ± 1.41 | 22.45 ± 1.51 | 19.39 ± 1.23 | 22.79 ± 1.30 | 22.25 ± 1.10 |
| 16:1(n-7) | 2.28 ± 0.64 | 1.72 ± 0.51 | 1.69 ± 0.51 | 2.22 ± 0.79 | 1.82 ± 0.71 | 1.87 ± 1.21 |
| 18:0 | 5.44 ± 0.58 | 8.18 ± 0.91 | 8.24 ± 0.90 | 5.71 ± 0.35 | 8.41 ± 0.67 | 8.71 ± 0.60 |
| 18:1T | 0.35 ± 0.11 | 0.38 ± 0.12 | 0.36 ± 0.12 | 0.38 ± 0.15 | 0.45 ± 0.19 | 0.42 ± 0.16 |
| 18:1(n-9) | 21.44 ± 1.63 | 17.79 ± 1.21 | 16.91 ± 1.02 | 21.12 ± 2.37 | 19.62 ± 3.09 | 17.77 ± 2.29 |
| 18:2(n-6) | 34.92 ± 2.88 | 30.20 ± 2.93 | 30.71 ± 3.00 | 34.92 ± 4.16 | 28.38 ± 3.90 | 29.41 ± 3.72 |
| 18:3(n-3) | 0.87 ± 0.22 | 0.67 ± 0.18 | 0.65 ± 0.18 | 0.87 ± 0.20 | 0.77 ± 0.23 | 0.69 ± 0.18 |
| 18:3(n-6) | 0.43 ± 0.14 | 0.28 ± 0.09 | 0.28 ± 0.01 | 0.53 ± 0.26 | 0.34 ± 0.20 | 0.35 ± 0.20 |
| 20:0 | 0.31 ± 0.04 | 0.26 ± 0.03 | 0.22 ± 0.03 | 0.26 ± 0.04*** | 0.23 ± 0.03*** | 0.19 ± 0.02** |
| 20:3(n-6) | 1.22 ± 0.29 | 1.85 ± 0.44 | 1.97 ± 0.49 | 1.34 ± 0.26 | 1.86 ± 0.39 | 2.09 ± 0.40 |
| 20:4(n-6) | 5.40 ± 0.91 | 7.08 ± 1.04 | 7.70 ± 1.20 | 5.53 ± 1.14 | 6.67 ± 1.42 | 7.64 ± 1.49 |
| 20:5(n-3) | 1.12 ± 0.59 | 1.28 ± 0.67 | 1.38 ± 0.75 | 1.26 ± 0.59 | 1.33 ± 0.55 | 1.50 ± 0.59 |
| 22:0 | 0.91 ± 0.10 | 0.75 ± 0.13 | 0.63 ± 0.14 | 0.86 ± 0.11 | 0.60 ± 0.12 | 0.55 ± 0.13 |
| 22:5(n-3) | 0.40 ± 0.11 | 0.65 ± 0.16 | 0.68 ± 0.16 | 0.47 ± 0.07** | 0.74 ± 0.12* | 0.82 ± 0.11** |
| 22:6(n-3) | 2.18 ± 0.50 | 3.46 ± 0.73 | 3.70 ± 0.79 | 1.96 ± 0.53 | 3.25 ± 0.86 | 3.37 ± 0.88 |
| 24:0 | 0.84 ± 0.07 | 0.65 ± 0.09 | 0.56 ± 0.08 | 0.83 ± 0.14 | 0.63 ± 0.13 | 0.56 ± 0.12 |
| 24:1(n-9) | 1.59 ± 0.21 | 1.43 ± 0.23 | 1.23 ± 0.21 | 1.39 ± 0.28** | 1.17 ± 0.24** | 1.04 ± 0.19* |
| ΣSAFA | 27.82 ± 1.21 | 33.21 ± 1.16 | 32.77 ± 1.23 | 27.88 ± 1.18 | 33.54 ± 1.50 | 32.94 ± 1.12 |
| ΣMUFA | 25.33 ± 2.03 | 20.98 ± 1.54 | 19.86 ± 1.34 | 24.48 ± 2.67 | 22.28 ± 3.16 | 20.51 ± 2.63 |
| ΣPUFA | 46.51 ± 2.55 | 45.44 ± 2.00 | 47.02 ± 1.82 | 47.26 ± 3.66 | 43.75 ± 4.13 | 46.14 ± 3.48 |
| PI | 83.2 ± 7.4 | 96.1 ± 8.3 | 101.2 ± 9.3 | 83.7 ± 9.2 | 92.2 ± 12.0 | 99.2 ± 10.9 |
Values are mean ± SD. * p < 0.05. ** p < 0.01, *** p < 0.001 compared to women. ΣSAFA, sum of percentages of saturated fatty acids, ΣMUFA, sum of percentages of monounsaturated fatty acids, ΣPUFA, sum of percentages of polyunsaturated fatty acids, PI, peroxidizability index (see methods).
Kinetic parameters of LDL, LDL + HDL2 and LDL + HDL3 oxidation in 59 healthy subjects.
| Lag time (min) | 60.9 ± 7.9 | 59.3 ± 6.9 | 60.2 ± 7.4 |
| Rate (μmol/l/min)a | 0.509 ± 0.067 | 0.502 ± 0.067 | 0.506 ± 0.066 |
| Max (nmol/mg)b | 541 ± 41 | 537 ± 51 | 539 ± 45 |
| Lag time (min) | 56.0 ± 5.7*** | 56.0 ± 6.7*** | 56.0 ± 6.1*** |
| Rate (μmol/l/min)a | 0.687 ± 0.062*** | 0.654 ± 0.084*** | 0.671 ± 0.073*** |
| Max (nmol/mg)b | 774 ± 40*** | 745 ± 71*** | 762 ± 56*** |
| Lag time (min) | 55.8 ± 5.4*** | 54.8 ± 5.4*** | 55.3 ± 5.4*** |
| Rate (μmol/l/min)a | 0.616 ± 0.064*** | 0.607 ± 0.070*** | 0.612 ± 0.066*** |
| Max (nmol/mg)b | 687 ± 40*** | 674 ± 60*** | 681 ± 50*** |
Values are mean ± SD. a Rate means maximal formation rate of conjugated dienes during oxidation. Calculation of the diene concentration is based on ε = 29500 of the conjugated dienes b Max is the maximal amount of dienes produced per mg of LDL protein. *** p < 0.001 in comparison with LDL alone in Wilcoxon's matched pairs test.
Multivariate regression models of factors predicting oxidation parameters in mixtures of LDL and HDL2.
| Dependent variable | Independent variable | Standardized regression coefficient β | p-Value | Total model |
| LDL + HDL2 | ||||
| Lag time (min) | fB-Glucose | 0.410 | 0.00037 | R2 = 0.296 |
| PI of HDL2 | -0.351 | 0.00276 | p < 0.00005 | |
| LDL + HDL2 | ||||
| Oxidation rate (μmol/ml/min) | ΣPUFA of LDL | 0.424 | 0.0325 | R2 = 0.57 |
| ΣPUFA of HDL2 | 0.352 | 0.0129 | p < 0.00000 | |
| LDL + HDL2 | ||||
| Maximum diene | HDL2 18:2n-6 | 0.429 | 0.00015 | R2 = 0.55 |
| concentration (nmol/mg) | LDL 18:1n-9 | -0.292 | 0.0071 | p < 0.00000 |
| LDL/apoB | 0.287 | 0.0033 |
Abbreviations: PI, peroxidizability index; ΣPUFA, sum of percentages of polyunsaturated fatty acids; LDL/apoB, the ratio of LDL cholesterol to apoB concentration. Stepwise forward regression analysis